Norges Bank
TSHA icon

Norges Bank’s Taysha Gene Therapies TSHA Stock Holding History

Norges Bank’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.2M Buy
+2,233,600
New +$13.2M ﹤0.01% 1240
2026
Q1 		– Sell
-1,837,800
Closed -$10.1M – 1302
2025
Q4 		$10.1M Buy
+1,837,800
New +$8.92M ﹤0.01% 1303
2025
Q1 		– Sell
-1,461,120
Closed -$2.53M – 1849
2024
Q4 		$2.53M Buy
+1,461,120
New +$3.03M ﹤0.01% 1660
2020
Q4 		– Sell
-10,000
Closed -$224K – 2161
2020
Q3 		$224K Buy
+10,000
New +$235K ﹤0.01% 2114

Other funds holding TSHA

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Norges Bank's TSHA Position: Q2 2026 in Review

Norges Bank opened a new position in Taysha Gene Therapies (TSHA) in Q2 2026: 2,233,600 shares worth $15.2M. The stake represents ﹤0.01% of the portfolio and ranks #1240 among its holdings. This is a return to the name: Norges Bank previously reported a position in TSHA as recently as Q4 2025.

Norges Bank first reported a position in TSHA in Q3 2020 and has held it in 4 quarters since. 208 funds tracked by Wall St. Rank hold TSHA as of Q2 2026.

  • Norges Bank held 2,233,600 shares of Taysha Gene Therapies worth $15.2M as of Q2 2026.
  • Taysha Gene Therapies was a new Norges Bank position in Q2 2026.
  • Taysha Gene Therapies made up ﹤0.01% of Norges Bank's portfolio in Q2 2026, its #1240 holding.
  • Norges Bank first reported a position in Taysha Gene Therapies in Q3 2020 and has held it in 4 quarters since.
  • 208 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q2 2026.

Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.